Literature DB >> 21088217

A Western-type diet accelerates tumor progression in an autochthonous mouse model of prostate cancer.

Gemma Llaverias1, Christiane Danilo, Yu Wang, Agnes K Witkiewicz, Kristin Daumer, Michael P Lisanti, Philippe G Frank.   

Abstract

Epidemiological studies have provided evidence suggesting an important role for diet and obesity in the development of cancer. Specifically, lipid nutrients of the diet have been identified as important regulators of tumor development and progression. In the present study, we have examined the role of dietary fat and cholesterol in the initiation and progression of prostate cancer using the well-characterized TRAMP mouse model. Consumption of a Western-type diet--that is, enriched in both fat and cholesterol--accelerated prostate tumor incidence and tumor burden compared to mice fed a control chow diet. Furthermore, we also show that this diet increased the extent and the histological grade of prostate tumors. These findings were confirmed by the presence of increased levels of protein markers of advanced tumors in prostates obtained from animals fed a Western-type diet compared to those obtained from control animals. Increased lung metastases in animals fed a Western-type diet were also observed. In addition, we found that with a Western diet, animals bearing tumors presented with reduced plasma cholesterol levels compared with animals fed a control diet. Finally, we show that tumors obtained from animals fed a Western-type diet displayed increased expression of the high-density lipoprotein receptor SR-BI and increased angiogenesis. Taken together, our data suggest that dietary fat and cholesterol play an important role in the development of prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21088217      PMCID: PMC2993263          DOI: 10.2353/ajpath.2010.100568

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  59 in total

Review 1.  Impact of diet on prostate cancer: a review.

Authors:  G A Sonn; W Aronson; M S Litwin
Journal:  Prostate Cancer Prostatic Dis       Date:  2005       Impact factor: 5.554

2.  The human breast carcinoma cell line HBL-100 acquires exogenous cholesterol from high-density lipoprotein via CLA-1 (CD-36 and LIMPII analogous 1)-mediated selective cholesteryl ester uptake.

Authors:  P J Pussinen; B Karten; A Wintersperger; H Reicher; M McLean; E Malle; W Sattler
Journal:  Biochem J       Date:  2000-07-15       Impact factor: 3.857

Review 3.  Problems with the assessment of dietary fat in prostate cancer studies.

Authors:  Leslie K Dennis; Linda G Snetselaar; Brian J Smith; Ron E Stewart; Michael E C Robbins
Journal:  Am J Epidemiol       Date:  2004-09-01       Impact factor: 4.897

4.  Effect of dietary fat on human breast cancer growth and lung metastasis in nude mice.

Authors:  D P Rose; J M Connolly; C L Meschter
Journal:  J Natl Cancer Inst       Date:  1991-10-16       Impact factor: 13.506

5.  Effect of isocaloric low-fat diet on human LAPC-4 prostate cancer xenografts in severe combined immunodeficient mice and the insulin-like growth factor axis.

Authors:  Tung H Ngo; R James Barnard; Pinchas Cohen; Stephen Freedland; Chris Tran; Frank deGregorio; Yahya I Elshimali; David Heber; William J Aronson
Journal:  Clin Cancer Res       Date:  2003-07       Impact factor: 12.531

6.  Dietary feeding of dibenzoylmethane inhibits prostate cancer in transgenic adenocarcinoma of the mouse prostate model.

Authors:  Tin Oo Khor; Siwang Yu; Avanthika Barve; Xingpei Hao; Jin-Liern Hong; Wen Lin; Barbara Foster; Mou-Tuan Huang; Harold L Newmark; Ah-Ng Kong
Journal:  Cancer Res       Date:  2009-08-25       Impact factor: 12.701

7.  No effect of a high-fat diet on promotion of sex hormone-induced prostate and mammary carcinogenesis in the Noble rat model.

Authors:  G Leung; I F F Benzie; A Cheung; S W Tsao; Y C Wong
Journal:  Br J Nutr       Date:  2002-10       Impact factor: 3.718

8.  Dysregulation of sterol response element-binding proteins and downstream effectors in prostate cancer during progression to androgen independence.

Authors:  Susan L Ettinger; Richard Sobel; Tanis G Whitmore; Majid Akbari; Dawn R Bradley; Martin E Gleave; Colleen C Nelson
Journal:  Cancer Res       Date:  2004-03-15       Impact factor: 12.701

9.  Promotional effects of testosterone and high fat diet on the development of autochthonous prostate cancer in rats.

Authors:  M Pollard; P H Luckert
Journal:  Cancer Lett       Date:  1986-08       Impact factor: 8.679

10.  Dietary fat, cholesterol and colorectal cancer in a prospective study.

Authors:  R Järvinen; P Knekt; T Hakulinen; H Rissanen; M Heliövaara
Journal:  Br J Cancer       Date:  2001-08-03       Impact factor: 7.640

View more
  51 in total

1.  Uptake of high-density lipoprotein by scavenger receptor class B type 1 is associated with prostate cancer proliferation and tumor progression in mice.

Authors:  C Alicia Traughber; Emmanuel Opoku; Gregory Brubaker; Jennifer Major; Hanxu Lu; Shuhui Wang Lorkowski; Chase Neumann; Aimalie Hardaway; Yoon-Mi Chung; Kailash Gulshan; Nima Sharifi; J Mark Brown; Jonathan D Smith
Journal:  J Biol Chem       Date:  2020-05-01       Impact factor: 5.157

2.  Mechanistic Study of Inhibitory Effects of Atorvastatin and Docetaxel in Combination on Prostate Cancer.

Authors:  Xuan Chen; Yue Liu; Jian Wu; Huarong Huang; Zhiyun Du; Kun Zhang; Daiying Zhou; Kaylyn Hung; Susan Goodin; Xi Zheng
Journal:  Cancer Genomics Proteomics       Date:  2016 Mar-Apr       Impact factor: 4.069

Review 3.  Diabetes, Obesity, and Breast Cancer.

Authors:  Chifei Kang; Derek LeRoith; Emily J Gallagher
Journal:  Endocrinology       Date:  2018-11-01       Impact factor: 4.736

4.  Development of animal models underlining mechanistic connections between prostate inflammation and cancer.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  World J Clin Oncol       Date:  2013-02-10

5.  Metabolic syndrome, dyslipidemia and prostate cancer recurrence after primary surgery or radiation in a veterans cohort.

Authors:  L C Macleod; L J Chery; E Y C Hu; S B Zeliadt; S K Holt; D W Lin; M P Porter; J L Gore; J L Wright
Journal:  Prostate Cancer Prostatic Dis       Date:  2015-03-31       Impact factor: 5.554

Review 6.  Metabolic targets for potential prostate cancer therapeutics.

Authors:  Jeffrey Twum-Ampofo; De-Xue Fu; Antonino Passaniti; Arif Hussain; M Minhaj Siddiqui
Journal:  Curr Opin Oncol       Date:  2016-05       Impact factor: 3.645

Review 7.  Lipid rafts as signaling hubs in cancer cell survival/death and invasion: implications in tumor progression and therapy: Thematic Review Series: Biology of Lipid Rafts.

Authors:  Faustino Mollinedo; Consuelo Gajate
Journal:  J Lipid Res       Date:  2020-11-07       Impact factor: 5.922

Review 8.  Lipid rafts as signaling hubs in cancer cell survival/death and invasion: implications in tumor progression and therapy.

Authors:  Faustino Mollinedo; Consuelo Gajate
Journal:  J Lipid Res       Date:  2020-01-27       Impact factor: 5.922

Review 9.  The emerging role of obesity, diet and lipid metabolism in prostate cancer.

Authors:  Matteo Ferro; Daniela Terracciano; Carlo Buonerba; Giuseppe Lucarelli; Danilo Bottero; Sisto Perdonà; Riccardo Autorino; Alessandro Serino; Francesco Cantiello; Rocco Damiano; Iulia Andras; Sabino De Placido; Giuseppe Di Lorenzo; Michele Battaglia; Barbara A Jereczek-Fossa; Vincenzo Mirone; Ottavio De Cobelli
Journal:  Future Oncol       Date:  2016-09-14       Impact factor: 3.404

10.  LXR, prostate cancer and cholesterol: the Good, the Bad and the Ugly.

Authors:  Hugues de Boussac; Aurélien Jc Pommier; Julie Dufour; Amalia Trousson; Françoise Caira; David H Volle; Silvère Baron; Jean-Marc A Lobaccaro
Journal:  Am J Cancer Res       Date:  2013-01-18       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.